Survey of the impact of BOLT-trial data on oncologists’ and dermatologists’ decision-making in treat...
Survey of the impact of BOLT-trial data on oncologists’ and dermatologists’ decision-making in treating patients with locally advanced basal cell carcinoma
About this item
Full title
Author / Creator
Publisher
PAGEPress Publications
Journal title
Language
English
Formats
Publication information
Publisher
PAGEPress Publications
Subjects
More information
Scope and Contents
Contents
Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multiple studies demonstrated that the aberrant activation of Hedgehog signaling is a driver of BCC development, and its blockade represents a potential therapeutic target. In Italy, clinicians can prescribe Hedgehog inhibitors (HhIs) Vismodegib and Sonidegib. To h...
Alternative Titles
Full title
Survey of the impact of BOLT-trial data on oncologists’ and dermatologists’ decision-making in treating patients with locally advanced basal cell carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_532de72c851f4cdb8b02316ca70fc097
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_532de72c851f4cdb8b02316ca70fc097
Other Identifiers
ISSN
2036-7392
E-ISSN
2036-7406
DOI
10.4081/dr.2024.9882
